|
ZNF70 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.576300E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.635800E-01 |
| Normal-vs-Stage2 |
1.172830E-01 |
| Normal-vs-Stage3 |
8.361400E-01 |
| Normal-vs-Stage4 |
4.430200E-01 |
| Stage1-vs-Stage2 |
2.723400E-01 |
| Stage1-vs-Stage3 |
6.333600E-01 |
| Stage1-vs-Stage4 |
2.326600E-01 |
| Stage2-vs-Stage3 |
2.486400E-01 |
| Stage2-vs-Stage4 |
1.012760E-01 |
| Stage3-vs-Stage4 |
4.599200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.620300E-02 |
| Normal-vs-AfricanAmerican |
5.866200E-01 |
| Normal-vs-Asian |
2.129900E-02 |
| Caucasian-vs-AfricanAmerican |
2.322400E-01 |
| Caucasian-vs-Asian |
5.236000E-03 |
| AfricanAmerican-vs-Asian |
7.966300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.971820E-01 |
| Normal-vs-Female |
1.556050E-02 |
| Male-vs-Female |
8.156400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.859400E-01 |
| Normal-vs-Extreme_Weight |
5.646400E-01 |
| Normal-vs-Obese |
7.974200E-02 |
| Normal-vs-Extreme_Obese |
1.278210E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.421200E-01 |
| Normal_Weight-vs-Obese |
3.491600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.051400E-01 |
| Extreme_Weight-vs-Obese |
2.361400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.658000E-01 |
| Obese-vs-Extreme_Obese |
9.293800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.347000E-01 |
| Normal-vs-Age(41-60Yrs) |
7.498000E-03 |
| Normal-vs-Age(61-80Yrs) |
3.498600E-01 |
| Normal-vs-Age(81-100Yrs) |
5.323000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.737600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.113600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.937790E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.463500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.627500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.294200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.317800E-03 |
| Normal-VS-Type2 PRCC |
1.399800E-01 |
| Normal-VS-KIRP CIMP |
5.683200E-01 |
| Normal-VS-Unclassified PRCC |
3.357700E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.07009999999763E-05 |
| Type1 PRCC-VS-KIRP CIMP |
1.304240E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.777000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.516800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.060420E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.165180E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.379000E-01 |
| Normal-vs-N1 |
6.772000E-01 |
| Normal-vs-N2 |
7.705800E-01 |
| N0-vs-N1 |
5.947800E-01 |
| N0-vs-N2 |
7.592600E-01 |
| N1-vs-N2 |
9.708000E-01 |
|
|
